AAAAAA
Results: 1-25/40
Authors:
Sever, PS
Dahlof, B
Poulter, NR
Wedel, H
Beevers, G
Caulfield, M
Collins, R
Kjeldsen, SE
McInnes, GT
Mehlsen, J
Nieminen, M
O'Brien, E
Ostergren, J
Citation: Ps. Sever et al., Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol, J HUM HYPER, 15, 2001, pp. S11-S12
Authors:
Papademetriou, V
Devereux, RB
Narayan, P
Wachtell, K
Bella, JN
Gerdts, E
Chrysant, SG
Dahlof, B
Citation: V. Papademetriou et al., Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: The LIFE study, AM J HYPERT, 14(8), 2001, pp. 768-774
Authors:
Okin, PM
Devereux, RB
Jern, S
Julius, S
Kjeldsen, SE
Dahlof, B
Citation: Pm. Okin et al., Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertropy in hypertensive patients: The LIFE study, AM J HYPERT, 14(8), 2001, pp. 775-782
Authors:
Dahlof, B
Citation: B. Dahlof, Left ventricular hypertrophy and angiotensin II antagonists, AM J HYPERT, 14(2), 2001, pp. 174-182
Authors:
Devereux, RB
Bella, J
Boman, K
Gerdts, E
Nieminen, MS
Rokkedal, J
Papademetriou, V
Wachtell, K
Wright, J
Paranicas, M
Okin, PM
Roman, MJ
Smith, G
Dahlof, B
Citation: Rb. Devereux et al., Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study, BLOOD PRESS, 10(2), 2001, pp. 74-82
Authors:
Okin, PM
Devereux, RB
Nieminen, MS
Jern, S
Oikarinen, L
Viitasalo, M
Toivonen, L
Kjeldsen, SE
Julius, S
Dahlof, B
Citation: Pm. Okin et al., Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: The LIFE study, J AM COL C, 38(2), 2001, pp. 514-520
Authors:
Sever, PS
Dahlof, B
Poulter, NR
Wedel, H
Beevers, G
Caulfield, M
Collins, R
Kjeldsen, SE
McInnes, GT
Mehlsen, J
Nieminen, M
O'Brien, E
Ostergren, J
Citation: Ps. Sever et al., Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial, J HYPERTENS, 19(6), 2001, pp. 1139-1147
Authors:
Zanchetti, A
Hansson, L
Dahlof, B
Elmfeldt, D
Kjeldsen, S
Kolloch, R
Larochelle, P
McInnes, GT
Mallion, JM
Ruilope, L
Wedel, H
Citation: A. Zanchetti et al., Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study, J HYPERTENS, 19(6), 2001, pp. 1149-1159
Authors:
Oikarinen, L
Nieminen, MS
Viitasalo, M
Toivonen, L
Wachtell, K
Papademetriou, V
Jern, S
Dahlof, B
Devereux, RB
Okin, PM
Citation: L. Oikarinen et al., Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study., J HYPERTENS, 19(10), 2001, pp. 1883-1891
Authors:
Bella, JN
Wachtell, K
Palmieri, V
Liebson, PR
Gerdts, E
Ylitalo, A
Koren, MJ
Pedersen, OL
Rokkedal, J
Dahlof, B
Roman, MJ
Devereux, RB
Citation: Jn. Bella et al., Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: The LIFE Study, J HYPERTENS, 19(1), 2001, pp. 127-134
Authors:
Lindholm, LH
Anderson, H
Ekbom, T
Hansson, L
Lanke, J
Dahlof, B
de Faire, U
Forsen, K
Hedner, T
Linjer, E
Schersten, B
Wester, PO
Moller, TR
Citation: Lh. Lindholm et al., Relation between drug treatment and cancer in hypertensives in the SwedishTrial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial, LANCET, 358(9281), 2001, pp. 539-544
Authors:
Devereux, RB
Palmieri, V
Sharpe, N
De Quattro, V
Bella, JN
de Simone, G
Walker, JF
Hahn, RT
Dahlof, B
Citation: Rb. Devereux et al., Effects of once-daily angiotensin-converting enzyme inhibition and calciumchannel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension - The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial, CIRCULATION, 104(11), 2001, pp. 1248-1254
Authors:
Dzau, VJ
Bernstein, K
Celermajer, D
Cohen, J
Dahlof, B
Deanfield, J
Diex, J
Drexler, H
Ferrari, R
van Gilst, W
Hansson, L
Hornig, B
Husain, A
Johnston, C
Lazar, H
Pepine, C
Rabelink, T
Remme, W
Ruilope, L
Ruzicka, M
Schunkert, H
Swedberg, K
Unger, T
Vaughan, D
Weber, M
Citation: Vj. Dzau et al., The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data, AM J CARD, 88(9A), 2001, pp. 1L-20L
Authors:
Zabalgoitia, M
Berning, J
Koren, MJ
Stoylen, A
Nieminen, MS
Dahlof, B
Devereux, RB
Citation: M. Zabalgoitia et al., Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study), AM J CARD, 88(6), 2001, pp. 646-650
Authors:
Wachtell, K
Rokkedal, J
Bella, JN
Aalto, T
Dahlof, B
Smith, G
Roman, MJ
Ibsen, H
Aurigemma, GP
Devereux, RB
Citation: K. Wachtell et al., Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE study), AM J CARD, 87(1), 2001, pp. 54-60
Authors:
Palmieri, V
Wachtell, K
Gerdts, E
Bella, JN
Papademetriou, V
Tuxen, C
Nieminen, MS
Dahlof, B
de Simone, G
Devereux, RB
Citation: V. Palmieri et al., Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: The LIFE Study, AM HEART J, 141(5), 2001, pp. 784-791
Authors:
Dahlof, B
Devereux, R
de Faire, U
Fyhrquist, F
Nieminen, MS
Ibsen, H
Julius, S
Kjeldsen, S
Kristianson, K
Lederballe-Pedersen, O
Lindholm, LH
Omvik, P
Oparil, S
Wedel, H
Citation: B. Dahlof et al., Losartan intervention for endpoint reduction in hypertension: The LIFE study, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 605-624
Authors:
Willenheimer, R
Dahlof, B
Gordon, A
Citation: R. Willenheimer et al., Clinical trials in cardiovascular medicine: are we looking for statisticalsignificance or clinical relevance?, HEART, 84(2), 2000, pp. 129-133
Authors:
Kjeldsen, SE
Dahlof, B
Devereux, RB
Julius, S
de Faire, U
Fyhrquist, F
Ibsen, H
Kristianson, K
Lederballe-Pedersen, O
Lindholm, LH
Nieminen, MS
Omvik, P
Oparil, S
Wedel, H
Citation: Se. Kjeldsen et al., Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study, AM J HYPERT, 13(8), 2000, pp. 899-906
Authors:
Devereux, RB
Roman, MJ
Palmieri, V
Okin, PM
Boman, K
Gerdts, E
Nieminen, MS
Papademetriou, V
Wachtell, K
Dahlof, B
Citation: Rb. Devereux et al., Left ventricular wall stresses and wall stress-mass-heart rate products inhypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study, J HYPERTENS, 18(8), 2000, pp. 1129-1138
Authors:
Lindholm, LH
Hansson, L
Ekbom, T
Dahlof, B
Lanke, J
Linjer, E
Schersten, B
Wester, PO
Hedner, T
de Faire, U
Citation: Lh. Lindholm et al., Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension - 2, J HYPERTENS, 18(11), 2000, pp. 1671-1675
Authors:
Willenheimer, R
Dahlof, B
Rydberg, R
Erhardt, L
Citation: R. Willenheimer et al., AT(1)-receptor blockers - A reply, EUR HEART J, 21(4), 2000, pp. 336-337
Authors:
Okin, PM
Devereux, RB
Jern, S
Kjeldsen, SE
Julius, S
Dahlof, B
Citation: Pm. Okin et al., Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients - The Losartan Intervention for Endpoint reduction (LIFE) in hypertension study, HYPERTENSIO, 36(5), 2000, pp. 766-773
Authors:
Wachtell, K
Bella, JN
Liebson, PR
Gerdts, E
Dahlof, B
Aalto, T
Roman, MJ
Papademetriou, V
Ibsen, H
Rokkedal, J
Devereux, RB
Citation: K. Wachtell et al., Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population - The LIFE study, HYPERTENSIO, 35(1), 2000, pp. 6-12
Authors:
Okin, PM
Jern, S
Devereux, RB
Kjeldsen, SE
Dahlof, B
Citation: Pm. Okin et al., Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients - The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study, HYPERTENSIO, 35(1), 2000, pp. 13-18